Clinical Trial Update: Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD) [Phase 3]

View source ↗

Summary

A Phase 3 multicenter study evaluating inhaled iloprost for pulmonary hypertension following repair of congenital heart disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Ventavis (iloprost)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Pulmonary Hypertension | Phase 3 | Status: COMPLETED